Accéder au contenu
Merck
  • Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.

Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.

The Journal of antibiotics (2009-01-10)
Anna N Tevyashova, Eugenia N Olsufyeva, Eugenia N Zbarsky, Jan Balzarini, Alexander A Shtil, Lyubov G Dezhenkova, Vladimir M Bukhman, Victor B Zbarsky, Maria N Preobrazhenskaya
RÉSUMÉ

A novel way of chemical modification of the antibiotic olivomycin I at the 2'-keto group of the side chain of the aglycone moiety was developed. Reaction of olivomycin I with the carboxymethoxylamine hemihydrochloride gave the key intermediate, 2'-carboxymethoxime-olivomycin I, which was further reacted with different amines in the presence of benzotriazol-1-yl-oxy-trispyrrolidinophosphonium hexafluorophosphate to give the corresponding amides. The antiproliferative and topoisomerase I (Topo-I)-poisoning activities of the novel derivatives were examined. One of the novel derivatives showed a marked inhibitory activity against Topo-I, a pronounced antitumor activity in in vivo experiments on mice bearing leukemia P-388 and lower toxic side effects compared with the parent olivomycin I.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2-Adamantylamine hydrochloride, 99%